SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cerner Corp – ‘10-Q’ for 9/30/17 – ‘R32’

On:  Friday, 10/27/17, at 4:02pm ET   ·   For:  9/30/17   ·   Accession #:  804753-17-39   ·   File #:  0-15386

Previous ‘10-Q’:  ‘10-Q’ on 7/28/17 for 7/1/17   ·   Next:  ‘10-Q’ on 5/3/18 for 3/31/18   ·   Latest:  ‘10-Q’ on 5/3/22 for 3/31/22   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/27/17  Cerner Corp                       10-Q        9/30/17   60:6M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    535K 
 2: EX-10.1     Material Contract                                   HTML     80K 
 8: EX-10.10    Material Contract                                   HTML    148K 
 3: EX-10.2     Material Contract                                   HTML     30K 
 4: EX-10.3     Material Contract                                   HTML     35K 
 5: EX-10.4     Material Contract                                   HTML     36K 
 6: EX-10.5     Material Contract                                   HTML     43K 
 7: EX-10.6     Material Contract                                   HTML     35K 
 9: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
10: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
11: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
12: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
19: R1          Document And Entity Information                     HTML     36K 
20: R2          Consolidated Balance Sheets                         HTML    105K 
21: R3          Consolidated Balance Sheets (Parenthetical)         HTML     25K 
22: R4          Consolidated Statements Of Operations               HTML     74K 
23: R5          Consolidated Statements Of Operations               HTML     20K 
                (Parenthetical)                                                  
24: R6          Consolidated Statements Of Comprehensive Income     HTML     31K 
25: R7          Consolidated Statements Of Comprehensive Income     HTML     22K 
                (Parenthetical)                                                  
26: R8          Consolidated Statements Of Cash Flows               HTML    101K 
27: R9          Interim Statement Presentation (Notes)              HTML     64K 
28: R10         Fair Value Measurements                             HTML     79K 
29: R11         Investments                                         HTML    120K 
30: R12         Receivables                                         HTML     39K 
31: R13         Income Taxes                                        HTML     21K 
32: R14         Earnings Per Share                                  HTML     87K 
33: R15         Share-Based Compensation                            HTML     88K 
34: R16         Contingencies                                       HTML     24K 
35: R17         Segment Reporting                                   HTML    124K 
36: R18         Fair Value Measurements (Tables)                    HTML     73K 
37: R19         Investments Investments (Tables)                    HTML    117K 
38: R20         Receivables (Tables)                                HTML     32K 
39: R21         Earnings Per Share (Tables)                         HTML     84K 
40: R22         Share-Based Compensation (Tables)                   HTML     91K 
41: R23         Segment Reporting (Tables)                          HTML    123K 
42: R24         Interim Statement Presentation Policies (Details)   HTML    111K 
43: R25         Fair Value Measurements (Narrative) (Details)       HTML     22K 
44: R26         Fair Value Measurements Fair Value, Assets and      HTML     43K 
                Liabilities Measured at Fair Value on a Recurring                
                Basis (Details)                                                  
45: R27         Investments (Narrative) (Details)                   HTML     19K 
46: R28         Investments (Details)                               HTML     52K 
47: R29         Receivables (Narrative) (Details)                   HTML     19K 
48: R30         Receivables (Summary Of Net Receivables) (Details)  HTML     31K 
49: R31         Income Taxes (Details)                              HTML     20K 
50: R32         Earnings Per Share (Reconciliation Of The           HTML     39K 
                Numerators And The Denominators Of The Basic And                 
                Diluted Per Share) (Details)                                     
51: R33         Earnings Per Share (Narrative) (Details)            HTML     25K 
52: R34         Share-Based Compensation (Schedule Of Stock         HTML     53K 
                Options Activity) (Details)                                      
53: R35         Share-Based Compensation (Schedule of Share-based   HTML     27K 
                Payment Award, Stock Options, Valuation                          
                Assumptions) (Details)                                           
54: R36         Share-Based Compensation (Schedule Of Non-Vested    HTML     40K 
                Shares Activity) (Details)                                       
55: R37         Share-Based Compensation (Compensation Expense      HTML     31K 
                Recognized In The Condensed Consolidated                         
                Statements Of Operations) (Details)                              
56: R38         Share-Based Compensation (Narrative) (Details)      HTML     38K 
57: R39         Segment Reporting (Summary Of The Operating         HTML     39K 
                Information) (Details)                                           
59: XML         IDEA XML File -- Filing Summary                      XML     90K 
58: EXCEL       IDEA Workbook of Financial Reports                  XLSX     51K 
13: EX-101.INS  XBRL Instance -- cern-20170930                       XML   1.54M 
15: EX-101.CAL  XBRL Calculations -- cern-20170930_cal               XML    149K 
16: EX-101.DEF  XBRL Definitions -- cern-20170930_def                XML    369K 
17: EX-101.LAB  XBRL Labels -- cern-20170930_lab                     XML    855K 
18: EX-101.PRE  XBRL Presentations -- cern-20170930_pre              XML    490K 
14: EX-101.SCH  XBRL Schema -- cern-20170930                         XSD     87K 
60: ZIP         XBRL Zipped Folder -- 0000804753-17-000039-xbrl      Zip    135K 


‘R32’   —   Earnings Per Share (Reconciliation Of The Numerators And The Denominators Of The Basic And Diluted Per Share) (Details)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.8.0.1
Earnings Per Share (Reconciliation Of The Numerators And The Denominators Of The Basic And Diluted Per Share) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Earnings Per Share [Abstract]        
Income available to common shareholders, basic $ 177,424 $ 169,979 $ 530,320 $ 486,793
Income available to common shareholders including assumed conversions, diluted $ 177,424 $ 169,979 $ 530,320 $ 486,793
Basic weighted average shares outstanding 331,993 338,684 331,319 338,675
Stock options and non-vested shares, incremental shares 6,787 6,133 6,627 6,242
Diluted weighted average shares outstanding 338,780 344,817 337,946 344,917
Basic earnings per share $ 0.53 $ 0.50 $ 1.60 $ 1.44
Diluted earnings per share $ 0.52 $ 0.49 $ 1.57 $ 1.41

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/27/17
For Period end:9/30/17
10/1/1610-Q
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/22  Cerner Corp.                      10-K       12/31/21  135:13M
 2/19/21  Cerner Corp.                      10-K       12/31/20  140:13M
Top
Filing Submission 0000804753-17-000039   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 12:42:44.1pm ET